NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $251,003 | -5.0% | 34,669 | -2.5% | 0.00% | – |
Q2 2023 | $264,077 | -67.3% | 35,542 | -69.5% | 0.00% | – |
Q1 2023 | $807,830 | +2.8% | 116,570 | +52.5% | 0.00% | – |
Q4 2022 | $785,886 | -63.4% | 76,448 | -35.3% | 0.00% | -100.0% |
Q3 2022 | $2,149,000 | -63.4% | 118,136 | +3.5% | 0.00% | -50.0% |
Q2 2022 | $5,867,000 | -34.5% | 114,099 | -6.2% | 0.00% | 0.0% |
Q1 2022 | $8,963,000 | -64.5% | 121,685 | -31.0% | 0.00% | -66.7% |
Q4 2021 | $25,246,000 | +100.6% | 176,457 | +190.7% | 0.01% | +100.0% |
Q3 2021 | $12,584,000 | +17.0% | 60,696 | +19.8% | 0.00% | 0.0% |
Q2 2021 | $10,757,000 | -49.5% | 50,662 | -56.9% | 0.00% | -50.0% |
Q1 2021 | $21,310,000 | +36.1% | 117,531 | -16.3% | 0.01% | +20.0% |
Q4 2020 | $15,660,000 | -15.1% | 140,428 | -17.5% | 0.01% | -16.7% |
Q3 2020 | $18,435,000 | -44.6% | 170,137 | -57.4% | 0.01% | -50.0% |
Q2 2020 | $33,267,000 | +368.7% | 399,127 | -23.6% | 0.01% | +300.0% |
Q1 2020 | $7,097,000 | – | 522,625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |